Quantifying proximity, confinement, and interventions in disease outbreaks: a decision support framework for air-transported pathogens

Abstract

The inability to communicate how infectious diseases are transmitted in human environments has triggered avoidance of interactions during the COVID-19 pandemic. We define a metric, Effective ReBreathed Volume (ERBV), that encapsulates how infectious pathogens transport in air. This measure distinguishes environmental transport from other factors in the chain of infection, thus allowing quantitative comparisons of the riskiness of different situations for any pathogens transported in air, including SARS-CoV-2. Particle size is a key factor in transport, removal onto surfaces, and elimination by mitigation measures, so ERBV is presented for a range of exhaled particle diameters: 1 μm, 10 μm, and 100 μm. Pathogen transport is enhanced by two separate but interacting effects: proximity and confinement. Confinement in enclosed spaces overwhelms proximity after 10–15 minutes for all but the largest particles. Therefore, we review plausible strategies to reduce the confinement effect. Changes in standard ventilation and filtration can reduce person-to-person transport of 1-μm particles (ERBV₁) by 13-85% in residential and commercial situations. Deposition to surfaces competes with intentional removal for 10-μm and 100-μm particles, so the same interventions reduce ERBV₁₀ by only 3-50%, and ERBV₁₀₀ is unaffected. Determining transmission modes is critical to identify intervention effectiveness, and would be accelerated with prior knowledge of ERBV. When judiciously selected, the interventions examined can provide substantial reduction in risk, and the conditions for selection are identified. The framework of size-dependent ERBV supports analysis and mitigation decisions in an emerging situation, even before other infectious parameters are well known.